Autores/as

  • A. Lligoña Unitat Alcohologia de la Generalitat de Catalunya. Institut de Malalties Digestives. Hospital Clínic de Barcelona.

DOI:

https://doi.org/10.20882/adicciones.655

Palabras clave:

Resumen

Citas

DSM IV Manual diagnóstico y estadístico de los trastornos mentales. Pp 267-276.

Sellers EM, Ciraulo DA, DuPont RL, Griffiths RR, Kosten TR, Romach MK et al. Alprazolam and benzodiacepine dependence. J Clin Psychiatry 1993; 54 (Supl. 10: 64-73.

Blandin PF: The use of clonazepam as an anticonvulsant: Clinical evaluation. Med J Aust 1973 1: 683-688.

Viscoot DS: Clordiazepoxide and hallucinations. Arch Gen Psychiatry 1968 19: 370-376.

Moldawsky RJ, Gottschalk LA: Adverse reactions, cardiotoxicity, and management of overdose. In Antianxiety Agents. Elsevier Science Publishers, New York, 1984 177-198.

Rickels K, Fox IL, Greenblatt DJ. Cloracepate and loracepam: clinical improvement and rebound anxiety. Am J Psychiatry 1988; 145: 312-317.

Rodrigo EK, King MB, Williams P. Health of long term benzodiacepine users. Br Med J 1988; 296:603-606.

Hallstrom C, Lader M. Benzodiacepine withdrawal phenomena. Int Pharmacopsychiatry 1981; 16:235-244.

Oliveros S, Hernández C, Baca E. Uso racional de las benzodiacepinas. En: Información Terapéutica del Sistema Nacional de Salud 1997 Vol 21 Nº 5: 113-126

Ciraulo DA et al. Abuse liability and clinicalpharmacokinetics of alprazolam in alcoholic men. J Clin Psychiatry 1988; 49: 333-337.

Ross HE. Benzodiacepine use and anxiolytic abus and dependence in treated alcoholics. Addiction 1993; 88: 209-218.

Tyrer P, Murphy S, Oates G, Kingdom D. Psychological treatment for benzodiacepine dependence. Lancet 1985; 1:1042-1043.

Sanchez-Craig M, Kay G, Busto U, Cappell H. Cognitive behavioural therapy for benzodiacepine dependence. Lancet 1986; 1: 388.

Descargas

Publicado

2000-12-15

Número

Sección

Editorial